Retrospective Study in Patients With Metastatic Renal Cancer Treated With TKI Sequence (Tyrosine Kinase Inhibitors of VEGFR) - mTOR- Axitinib Inhibitors or Anti-VEGF Antibody -Inhibiteurs mTOR - Axitinib
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Axitinib (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 28 Apr 2017 New trial record